US market prospects for Indian pharma brighten as shortages and new generics reshape profits

Published on 24 April 2026

Drug shortages are helping prices, but the catch remains

Indian pharma’s US outlook has improved after years of pressure from price erosion and compliance hurdles. Drug shortages have temporarily slowed price erosion, while launches of key generic drugs have helped companies regain footing. Yet the real question is sustainability: will the same conditions hold, or will competition and supply normalization bring renewed margin stress?

Drug shortages have reduced price erosion for Indian generics in the US
New key generic launches are helping companies recover market share
Compliance issues previously weighed heavily on performance
The big uncertainty is whether these gains can last

#indian pharma #drug shortages #us market #generic drugs #drug pricing

Read the full story at The Economic Times

This summarization was done by Beige for a story published on The Economic Times

US market prospects for Indian pharma brighten as shortages and new generics reshape profits

The full experience is on mobile.